Advertisement
TRVI vs TSHA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVI is a Hold and TSHA is a Hold.
TRVI's Indicator enters downward trend
The Aroon Indicator for TRVI entered a downward trend on October 16, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 180 similar instances where the Aroon Indicator formed such a pattern. In 169 of the 180 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRVI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
TRVI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.382) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. TRVI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
TSHA sees MACD Histogram crosses below signal line
TSHA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 40 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 50-day moving average for TSHA moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TSHA entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in 215 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
TSHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.198) is normal, around the industry mean (26.782). P/E Ratio (2.698) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. TSHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TRVI | TSHA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 44 Fair valued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 34 | 100 | |
SMR RATING 1..100 | 95 | 98 | |
PRICE GROWTH RATING 1..100 | 65 | 87 | |
P/E GROWTH RATING 1..100 | 100 | 98 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TRVI's Valuation (44) in the Pharmaceuticals Major industry is in the same range as TSHA (61) in the null industry. This means that TRVI’s stock grew similarly to TSHA’s over the last 12 months.
TRVI's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for TSHA (100) in the null industry. This means that TRVI’s stock grew significantly faster than TSHA’s over the last 12 months.
TRVI's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as TSHA (98) in the null industry. This means that TRVI’s stock grew similarly to TSHA’s over the last 12 months.
TRVI's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as TSHA (87) in the null industry. This means that TRVI’s stock grew similarly to TSHA’s over the last 12 months.
TSHA's P/E Growth Rating (98) in the null industry is in the same range as TRVI (100) in the Pharmaceuticals Major industry. This means that TSHA’s stock grew similarly to TRVI’s over the last 12 months.
| TRVI | TSHA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 1 day ago 84% |
| Stochastic ODDS (%) | 5 days ago 84% | 1 day ago 90% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 88% |
| Advances ODDS (%) | N/A | 25 days ago 81% |
| Declines ODDS (%) | 3 days ago 86% | 3 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TRVI’s FA Score shows that 0 FA rating(s) are green while TSHA’s FA Score has 0 green FA rating(s).
- TRVI’s FA Score: 0 green, 5 red.
- TSHA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TRVI’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).
- TRVI’s TA Score: 3 bullish, 2 bearish.
- TSHA’s TA Score: 4 bullish, 4 bearish.
Price Growth
TRVI (@Biotechnology) experienced а -9.93% price change this week, while TSHA (@Biotechnology) price change was -19.38% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
TRVI is expected to report earnings on Nov 11, 2026.
TSHA is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PEY | 23.61 | 0.04 | +0.18% |
| Invesco High Yield Equity Dividend Achievers ETF (PEY) | |||
| QLTI | 27.33 | -0.06 | -0.21% |
| GMO International Quality ETF | |||
| XYZY | 23.46 | -0.22 | -0.92% |
| YieldMax XYZ Option Income Strategy ETF (XYZY) | |||
| GLOW | 34.25 | -0.35 | -1.01% |
| VictoryShares WestEnd Global Equity ETF (GLOW) | |||
| ENO | 19.35 | -0.33 | -1.68% |
| Entergy New Orleans LLC | |||
TRVI and
Correlation & Price change
A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with TSHA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then TSHA could also see price increases.
| Ticker / NAME | Correlation To TRVI | 1D Price Change % | ||
|---|---|---|---|---|
| TRVI | 100% | -1.90% | ||
| TSHA - TRVI | 46% Loosely correlated | -2.95% | ||
| SYRE - TRVI | 42% Loosely correlated | -0.25% | ||
| PVLA - TRVI | 42% Loosely correlated | -5.53% | ||
| PTGX - TRVI | 41% Loosely correlated | -5.71% | ||
| ORKA - TRVI | 41% Loosely correlated | -2.63% | ||
More | ||||